DRACP05496 |
sgRNA-CPP |
CGGGRRRRRRRRRLLLL |
17 |
Synthetic |
DRACP05497 |
DS4.3 |
RIMRILRILKLAR |
13 |
Protein derived |
DRACP05498 |
Tat |
RKKRRQRRRGGG |
12 |
Protein derived |
DRACP05499 |
TatLK15 |
RKKRRQRRRGGGKLLKLLLKLLLKLLK |
27 |
Chimeric |
DRACP05500 |
MPGα |
GALFLAFLAAALSLMGLWSQPKKKRKV |
27 |
Synthetic |
DRACP05501 |
CPPP-2 |
KLPVM |
5 |
Synthetic |
DRACP05502 |
pepM |
KLFMALVAFLRFLTIPPTAGILKRWGTI |
28 |
Synthetic |
DRACP05503 |
pepR |
LKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR |
35 |
Synthetic |
DRACP05504 |
Alexa488-Melan-A-TAT |
CELAGIGILTVRKKRRQRRR |
20 |
Chimeric |
DRACP05505 |
Alexa488-Melan-A-polyLys (control peptide) |
CELAGIGILTVKKKKKQKKK |
20 |
Synthetic |
DRACP05506 |
RTAT-ELPBC |
YGRGGRRGRRR |
11 |
Synthetic |
DRACP05507 |
IA0 (Bicyclic) (integral arginine peptides) |
XACSGSGSGCGSGSGSCG |
18 |
Synthetic |
DRACP05508 |
IA2 |
XACSGRGSGCGSGRGSCG |
18 |
Synthetic |
DRACP05509 |
IA4a |
XACRGSGRGCGRGSGRCG |
18 |
Synthetic |
DRACP05510 |
IA4b |
XACSGRGRGCGRGRGSCG |
18 |
Synthetic |
DRACP05511 |
IA6a |
XACRGRGRGCGRGRGRCG |
18 |
Synthetic |
DRACP05512 |
IA6b |
XACGRGRGRCRGRGRGCG |
18 |
Synthetic |
DRACP05513 |
IA6c |
XACRGRGRGCRGRGRGCG |
18 |
Synthetic |
DRACP05514 |
IA6d |
XACGRGRGRCGRGRGRCG |
18 |
Synthetic |
DRACP05515 |
IA8a |
XACRGRRRGCGRRRGRCG |
18 |
Synthetic |
DRACP05516 |
IA8b |
XACRRSRRGCGRRSRRCG |
18 |
Synthetic |
DRACP05517 |
kCA2 (Kallikrein inhibitor with internal arginines) |
XACSDRFRNCPADEALCG |
18 |
Synthetic |
DRACP05518 |
kCA3 |
XACRDRFRNCPADEALCG |
18 |
Synthetic |
DRACP05519 |
kCA4 |
XACRDRFRNCPADERLCG |
18 |
Synthetic |
DRACP05520 |
kCA5 |
XACRDRFRRCPADERLCG |
18 |
Synthetic |
DRACP05521 |
kCA6 |
XACRDRFRRCPADRRLCG |
18 |
Synthetic |
DRACP05522 |
CA2 (Control internal arginine ) |
XACSGRGRGCGSGSGSCG |
18 |
Synthetic |
DRACP05523 |
CA3 |
XACRGRGRGCGSGSGSCG |
18 |
Synthetic |
DRACP05524 |
CA4 |
XACRGRGRGCGSGSRSCG |
18 |
Synthetic |
DRACP05525 |
CA5 |
XACRGRGRRCGSGSRSCG |
18 |
Synthetic |